Literature DB >> 2157884

Heterotypic protection induced by synthetic peptides corresponding to three serotypes of foot-and-mouth disease virus.

T R Doel1, C Gale, C M Do Amaral, G Mulcahy, R Dimarchi.   

Abstract

Synthetic peptide vaccines of the general sequence Cys-Cys(200-213)-Pro-Pro-Ser-(141-158)-Pro-Cys-Gly, where the numbered residues refer to VP1 sequences of three different strains of foot-and-mouth disease virus, have been evaluated in cattle and guinea pigs. High levels of serotype-specific (homotypic) antiviral and antipeptide antibody were produced with each peptide. The A- and O-serotype peptides provided complete protection of guinea pigs against their respective virus challenges. The C-serotype peptide appeared to be less effective than the other peptides. In cross-protection studies (heterotypic) in guinea pigs, it was possible to protect A-serotype peptide-vaccinated animals against O-virus challenge and vice versa. Some heterotypic protection was also achieved with the C-serotype peptide. The heterotypic protection observed related more to the presence of cross-reactive antipeptide antibody than to neutralizing antibody.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157884      PMCID: PMC249387          DOI: 10.1128/JVI.64.5.2260-2264.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Immunization against foot-and-mouth disease with synthetic peptides representing the C-terminal region of VP1.

Authors:  T R Doel; C Gale; G Brooke; R DiMarchi
Journal:  J Gen Virol       Date:  1988-09       Impact factor: 3.891

2.  Extensive antigenic heterogeneity of foot-and-mouth disease virus of serotype C.

Authors:  M G Mateu; J L Da Silva; E Rocha; D L De Brum; A Alonso; L Enjuanes; E Domingo; H Barahona
Journal:  Virology       Date:  1988-11       Impact factor: 3.616

3.  A physico-chemical sub-grouping of the mammalian picornaviruses.

Authors:  J F Newman; D J Rowlands; F Brown
Journal:  J Gen Virol       Date:  1973-02       Impact factor: 3.891

4.  Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine.

Authors:  D G Kleid; D Yansura; B Small; D Dowbenko; D M Moore; M J Grubman; P D McKercher; D O Morgan; B H Robertson; H L Bachrach
Journal:  Science       Date:  1981-12-04       Impact factor: 47.728

5.  Further developments in the quantification of small RNA viruses by U.V. photometry of sucrose density gradients.

Authors:  T R Doel; B W Fletton; R F Staple
Journal:  Dev Biol Stand       Date:  1981

6.  Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence.

Authors:  J L Bittle; R A Houghten; H Alexander; T M Shinnick; J G Sutcliffe; R A Lerner; D J Rowlands; F Brown
Journal:  Nature       Date:  1982-07-01       Impact factor: 49.962

7.  Radial immuno-diffusion and serum-neutralisation techniques for the assay of antibodies to swine vesicular disease.

Authors:  S M Golding; R S Hedger; P Talbot
Journal:  Res Vet Sci       Date:  1976-03       Impact factor: 2.534

8.  Location and characterization of the antigenic portion of the FMDV immunizing protein.

Authors:  K Strohmaier; R Franze; K H Adam
Journal:  J Gen Virol       Date:  1982-04       Impact factor: 3.891

9.  Synthesis of the antibacterial peptide cecropin A (1-33).

Authors:  R B Merrifield; L D Vizioli; H G Boman
Journal:  Biochemistry       Date:  1982-09-28       Impact factor: 3.162

10.  Thermal stability of foot-and-mouth disease virus.

Authors:  T R Doel; P J Baccarini
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

View more
  11 in total

1.  A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants.

Authors:  O Taboga; C Tami; E Carrillo; J I Núñez; A Rodríguez; J C Saíz; E Blanco; M L Valero; X Roig; J A Camarero; D Andreu; M G Mateu; E Giralt; E Domingo; F Sobrino; E L Palma
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

2.  MHC class II restricted recognition of FMDV peptides by bovine T cells.

Authors:  E J Glass; R A Oliver; T Collen; T R Doel; R Dimarchi; R L Spooner
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

3.  First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs.

Authors:  J P Langeveld; J I Casal; A D Osterhaus; E Cortés; R de Swart; C Vela; K Dalsgaard; W C Puijk; W M Schaaper; R H Meloen
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

4.  Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot-and-mouth disease capsid protein epitopes on surface of hybrid virus particles.

Authors:  S Kit; M Kit; R D DiMarchi; S P Little; C Gale
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

5.  Promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine.

Authors:  Jun-Jun Shao; Chung Kai Wong; Tong Lin; Shuk Kwan Lee; Guo-Zheng Cong; Fion Wai Yee Sin; Jun-Zheng Du; Shan-Dian Gao; Xiang-Tao Liu; Xue-Peng Cai; Yong Xie; Hui-Yun Chang; Ji-Xing Liu
Journal:  Clin Vaccine Immunol       Date:  2010-11-17

6.  Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites.

Authors:  M G Mateu; J Hernández; M A Martínez; D Feigelstock; S Lea; J J Pérez; E Giralt; D Stuart; E L Palma; E Domingo
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

Review 7.  Need for cellular and humoral immune responses in bovines to ensure protection from foot-and-mouth disease virus (FMDV)--a point of view.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1994-07       Impact factor: 2.332

8.  Cross-reactive and serotype-specific antibodies against foot-and-mouth disease virus generated by different regions of the same synthetic peptide.

Authors:  T R Doel; C M Doel; R F Staple; R DiMarchi
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

9.  Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle.

Authors:  M J van Lierop; K van Maanen; R H Meloen; V P Rutten; M A de Jong; E J Hensen
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

10.  Intranasal immunization of guinea pigs with an immunodominant foot-and-mouth disease virus peptide conjugate induces mucosal and humoral antibodies and protection against challenge.

Authors:  D Fischer; D Rood; R W Barrette; A Zuwallack; E Kramer; F Brown; L K Silbart
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.